Scientific paper - Case study
Severe Lipoatrophy in a Patient With Type 2 Diabetes in Response to Human Insulin Analogs Glargine and Degludec: Possible Involvement of CD4 T Cell–Mediated Tissue Remodeling
Diabetes Care, 43 (2019), 2; 494-196. https://doi.org/10.2337/dc19-1888


Cite this document

Turk Wensveen, T., Fučkar Čupić, D., Jurišić Eržen, D., Polić, B. & Wensveen, F. M. (2019). Severe Lipoatrophy in a Patient With Type 2 Diabetes in Response to Human Insulin Analogs Glargine and Degludec: Possible Involvement of CD4 T Cell–Mediated Tissue Remodeling. Diabetes Care, 43. (2), 494-196. doi: 10.2337/dc19-1888

Turk Wensveen, Tamara, et al. "Severe Lipoatrophy in a Patient With Type 2 Diabetes in Response to Human Insulin Analogs Glargine and Degludec: Possible Involvement of CD4 T Cell–Mediated Tissue Remodeling." Diabetes Care, vol. 43, no. 2, 2019, pp. 494-196. https://doi.org/10.2337/dc19-1888

Turk Wensveen, Tamara, Dora Fučkar Čupić, Dubravka Jurišić Eržen, Bojan Polić and Felix M. Wensveen. "Severe Lipoatrophy in a Patient With Type 2 Diabetes in Response to Human Insulin Analogs Glargine and Degludec: Possible Involvement of CD4 T Cell–Mediated Tissue Remodeling." Diabetes Care 43, no. 2 (2019): 494-196. https://doi.org/10.2337/dc19-1888

Turk Wensveen, T., et al. (2019) 'Severe Lipoatrophy in a Patient With Type 2 Diabetes in Response to Human Insulin Analogs Glargine and Degludec: Possible Involvement of CD4 T Cell–Mediated Tissue Remodeling', Diabetes Care, 43(2), pp. 494-196. doi: 10.2337/dc19-1888

Turk Wensveen T, Fučkar Čupić D, Jurišić Eržen D, Polić B, Wensveen FM. Severe Lipoatrophy in a Patient With Type 2 Diabetes in Response to Human Insulin Analogs Glargine and Degludec: Possible Involvement of CD4 T Cell–Mediated Tissue Remodeling. Diabetes Care [Internet]. 2019 [cited 2024 June 18];43(2):494-196. doi: 10.2337/dc19-1888

T. Turk Wensveen, D. Fučkar Čupić, D. Jurišić Eržen, B. Polić and F. M. Wensveen, "Severe Lipoatrophy in a Patient With Type 2 Diabetes in Response to Human Insulin Analogs Glargine and Degludec: Possible Involvement of CD4 T Cell–Mediated Tissue Remodeling", Diabetes Care, vol. 43, no. 2, pp. 494-196, 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:925629. [Accessed: 18 June 2024]